Trial · NCT03470441
Registered outcomes19
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 19 of 19
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Arrhythmias of Interest, 48 Hours (Overall) | First 48 hours post-treatment | Number of patients experiencing clinically relevant arrhythmias during the first 48 hours post-treatment. |
| Primary | Arrhythmias of Interest Incidence Rate, 48 Hours (Overall) | 48 hours post-treatment | Incidence rate of clinically relevant arrhythmias during the first 48 hours post-treatment defined as the number of patients who experienced an arrhythmia divided by the total person-monitoring time within each treatment group |
| Primary | Arrhythmias of Interest, 14 Days (Overall) | 48 hours to 14 days Post Percutaneous Coronary Intervention (PCI) | Number of patients experiencing clinically relevant arrhythmias 48 hours to 14 days post-treatment. |
| Primary | Arrhythmias of Interest Incidence Rate, 14 Days (Overall) | 48 hours to 14 days Post Percutaneous Coronary Intervention (PCI) | Incidence rate of clinically relevant arrhythmias 48 hours to 14 days post-treatment defined as the number of patients who experienced an arrhythmia divided by the total person-monitoring time within each treatment group |
| Secondary | Infarct Size Relative to Ventricular Volume, 72 Hours (Overall) | 72 hours post-treatment | Infarct size relative to ventricular volume (INF/VV) at 72 hours post-treatment |
| Secondary | Infarct Size Relative to Ventricular Volume, 3 Months (Overall) | 3 months post-treatment | Infarct size relative to ventricular volume (INF/VV) at 3 months post-treatment) |
| Secondary | Infarct Size Relative to Ventricular Volume, 72 Hours (Anterior Infarcts) | 72 hours post-treatment | Infarct size relative to ventricular volume (INF/VV) at 72 hours post-treatment) |
| Secondary | Infarct Size Relative to Ventricular Volume, 3 Months (Anterior Infarcts) | 3 months post-treatment | Infarct size relative to ventricular volume (INF/VV) at 3 months post-treatment) |
| Secondary | Left Ventricular End Systolic Volume Index, 72 Hours (Overall) | 72 hours post-treatment | Left ventricular end systolic volume index (LVESVi) at 72 hours post-treatment |
| Secondary | Left Ventricular End Systolic Volume Index, 3 Months (Overall) | 3 months post-treatment | Left ventricular end systolic volume index (LVESVi) at 3 Months post-treatment |
| Secondary | Left Ventricular End Systolic Volume Index, 72 Hours (Anterior Infarcts) | 72 hours post-treatment | Left ventricular end systolic volume index (LVESVi) at 72 Hours post-treatment |
| Secondary | Left Ventricular End Systolic Volume Index, 3 Months (Anterior Infarcts) | 3 months post-treatment | Left ventricular end systolic volume index (LVESVi) at 3 Months post-treatment |
| Secondary | Left Ventricular Ejection Fraction, 72 Hours (Overall) | 72 hours post-treatment | Left ventricular ejection fraction at 72 hours post-treatment |
| Secondary | Left Ventricular Ejection Fraction, 3 Months (Overall) | 3 months post-treatment | Left Ventricular Ejection Fraction at 3 Months (Overall) |
| Secondary | Left Ventricular Ejection Fraction, 72 Hours (Anterior Infarcts) | 72 hours post-treatment | Left ventricular ejection fraction at 72 hours post-treatment |
| Secondary | Left Ventricular Ejection Fraction, 3 Months (Anterior Infarcts) | 3 months post-treatment | Left Ventricular Ejection Fraction at 3 Months (Anterior Infarcts) |
| Secondary | Serum Troponin Concentrations, 48 Hours (Overall) | 48 hours post-treatment | Area under the curve of serum troponins measured over 48 hours post-treatment |
| Secondary | Serum Troponin Concentrations, 48 Hours (Anterior Infarcts) | 48 hours post-treatment | Area under the curve of serum troponins measured over 48 hours post-treatment |
| Secondary | ST-segment Resolution | 4 hours post-dose | Proportion of patients with ST-segment resolution at 4 hours post-dose |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03470441/registered